S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-0.15%) $77.99
Gas
(0.37%) $2.15
Gold
(0.06%) $2 310.10
Silver
(0.36%) $26.79
Platinum
(0.09%) $966.20
USD/EUR
(-0.38%) $0.929
USD/NOK
(-1.10%) $10.87
USD/GBP
(-0.14%) $0.797
USD/RUB
(0.52%) $91.61

Realaus laiko atnaujinimai Medical Developments [MVP.AX]

Birža: ASX Pramonė: Pharmaceuticals, Biotechnology & Life Sciences
Atnaujinta3 geg. 2024 @ 09:10

4.44% $ 0.470

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 09:10):

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally...

Stats
Šios dienos apimtis 48 812.00
Vidutinė apimtis 191 248
Rinkos kapitalizacija 40.56M
EPS $0 ( 2024-02-28 )
Last Dividend $0.0197 ( 2020-03-05 )
Next Dividend $0 ( N/A )
P/E -2.04
ATR14 $0.00300 (0.64%)

Tūris Koreliacija

Ilgas: -0.07 (neutral)
Trumpas: 0.42 (neutral)
Signal:(58.756) Neutral

Medical Developments Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Medical Developments Koreliacija - Valiuta/Žaliavos

The country flag 0.27
( neutral )
The country flag 0.35
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.01
( neutral )

Medical Developments Finansinės ataskaitos

Annual 2023
Pajamos: $32.34M
Bruto pelnas: $-2.52M (-7.78 %)
EPS: $-0.0666
FY 2023
Pajamos: $32.34M
Bruto pelnas: $-2.52M (-7.78 %)
EPS: $-0.0666
FY 2022
Pajamos: $21.94M
Bruto pelnas: $-3.06M (-13.95 %)
EPS: $-0.170
FY 2021
Pajamos: $25.27M
Bruto pelnas: $19.10M (75.57 %)
EPS: $-0.194

Financial Reports:

No articles found.

Medical Developments Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Medical Developments Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.00246 2004-10-13
Last Dividend $0.0197 2020-03-05
Next Dividend $0 N/A
Payout Date 2020-04-17
Next Payout Date N/A
# dividends 15 --
Total Paid Out $0.317 --
Avg. Dividend % Per Year 0.00% --
Score 0.65 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2025-05-02)
$0 Estimate 0.00 %
Dividend Stability
0.04 Very Bad
Dividend Score
0.65
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
IFT.AX Ex Dividend Knight 2023-05-29 Semi-Annually 0 0.00%
SFC.AX Ex Dividend Knight 2023-09-07 Semi-Annually 0 0.00%
CD1.AX Ex Dividend Junior 2023-08-17 Semi-Annually 0 0.00%
MEZ.AX Ex Dividend Knight 2023-09-06 Semi-Annually 0 0.00%
TOP.AX Ex Dividend Knight 2023-09-07 Semi-Annually 0 0.00%
CWP.AX Ex Dividend Junior 2023-09-27 Semi-Annually 0 0.00%
NSR.AX Ex Dividend Knight 2023-06-29 Semi-Annually 0 0.00%
FID.AX Ex Dividend Knight 2023-08-25 Semi-Annually 0 0.00%
PRU.AX Ex Dividend Knight 2023-09-12 Semi-Annually 0 0.00%
ASG.AX Ex Dividend Junior 2023-10-31 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.5741.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.2111.200-7.03-8.44[0 - 0.3]
returnOnEquityTTM-0.2451.500-3.83-5.75[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.780.8001.0910.873[1 - 3]
quickRatioTTM1.8410.8003.883.10[0.8 - 2.5]
cashRatioTTM1.4071.5003.294.94[0.2 - 2]
debtRatioTTM0.0266-1.5009.56-10.00[0 - 0.6]
interestCoverageTTM-279.141.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM-0.1642.00-0.0547-0.109[0 - 30]
freeCashFlowPerShareTTM-0.2392.00-0.119-0.239[0 - 20]
debtEquityRatioTTM0.0321-1.5009.87-10.00[0 - 2.5]
grossProfitMarginTTM-0.2151.000-6.91-6.91[0.2 - 0.8]
operatingProfitMarginTTM-0.7501.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-5.841.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.3680.800-0.881-0.705[0.5 - 2]
Total Score-3.42

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-2.111.000-0.3140[1 - 100]
returnOnEquityTTM-0.2452.50-2.46-5.75[0.1 - 1.5]
freeCashFlowPerShareTTM-0.2392.00-0.0796-0.239[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.1642.00-0.0547-0.109[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.007401.500-3.380[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.4231.000-10.000[0.1 - 0.5]
Total Score-2.18

Medical Developments

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease; Penthrox, a trauma and emergency pain relief product; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, oxygen resuscitation kits, oxygen therapy masks, and resuscitators. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.